BioNTech to scale down manufacturing, over 1,800 jobs on the line

BioNTech said that up to 1,860 manufacturing staff could be impacted by the downsizing. It is set to end operations in Idar-Oberstein and Marburg, both in Germany, as well as in Singapore. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals…

Source: Endpoints News